Related Experiment Video
Updated: Aug 15, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Renal ontogeny of ifosfamide nephrotoxicity
Katarina Aleksa1, Naomi Halachmi, Shinya Ito
1Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Younger children are more vulnerable to ifosfamide-induced kidney damage. This study reveals age-related changes in cytochrome P450 enzyme activity, explaining ifosfamide nephrotoxicity in pediatric cancer patients.
Area of Science:
- Pharmacology
- Toxicology
- Pediatric Oncology
Background:
- Ifosfamide chemotherapy can cause kidney damage, particularly in young children.
- The mechanisms behind this age-dependent nephrotoxicity are not fully understood.
- Cytochrome P450 (CYP) enzymes are implicated in metabolizing ifosfamide into toxic byproducts.
Purpose of the Study:
- To investigate the role of renal ontogeny in ifosfamide-induced nephrotoxicity.
- To evaluate the age-dependent expression and activity of renal CYP enzymes involved in ifosfamide metabolism.
- To determine if developmental changes in CYP activity correlate with age-related kidney damage.
Main Methods:
- Assessed renal CYP3A and 2B22 activity in pigs from 1 day old to adulthood.
- Measured ifosfamide metabolism by renal microsomes to 2- and 3-dechloroethylifosfamide.
- Quantified kidney CYP3A messenger RNA expression over different age groups.
Main Results:
- Renal CYP3A messenger RNA expression peaked in young pigs (15-60 days) and then decreased to adult levels.
- Ifosfamide metabolism rate increased significantly from young to adult animals.
- This is the first study to document the ontogeny of renal CYP3A and ifosfamide metabolism.
Conclusions:
- Age-dependent ifosfamide nephrotoxicity is partly explained by developmental changes in renal CYP3A activity.
- Ontogeny of CYP enzymes influences the production of nephrotoxic chloroacetaldehyde.
- These findings are crucial for understanding and mitigating ifosfamide-induced kidney damage in pediatric cancer patients.
Abstract:
Ifosfamide-induced nephrotoxicity adversely affects the health and well-being of children with cancer. We have recently shown age-dependent nephrotoxicity induced by ifosfamide, with younger children (<3 years) substantially more vulnerable. The mechanisms leading to this age-related ifosfamide-induced renal damage have not been identified. Underlying this work is the hypothesis that renal ontogeny is involved in the expression and activity of the cytochrome P450 (CYP) enzymes responsible for IF metabolism to the nephrotoxic chloroacetaldehyde. We evaluated renal CYP3A and 2B22 activity in pigs between the ages of 1 day and adulthood, as well as the metabolism of ifosfamide by renal microsomes to 2- and 3-dechloroethylifosfamide (2-DCEIF and 3-DCEIF, respectively). Kidney CYP3A messenger RNA expression peaked 15 to 60 days (0.7-76 +/- 0.19 CYP3A/actin ratio; P < 0.001). Subsequently, this level decreased to adult values (0.54 - 0.03 CYP3A/actin ratio; P = 0.04). Similarly, we detected an increase in the ifosfamide-metabolism rate between young (18 +/- 2 pmol/mg protein/min) and adult (12.2 +/- 0.17 pmol/mg protein/min) animals (P = 0.002). Ours is the first documentation of ontogeny of renal CYP3A and of renal ifosfamide metabolism. These data suggest that age-dependent ifosfamide nephrotoxicity is, at least in part, due to ontogeny in the production chloroacetaldehyde.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

